Literature DB >> 11247708

Search for primary infection by Pneumocystis carinii in a cohort of normal, healthy infants.

S L Vargas1, W T Hughes, M E Santolaya, A V Ulloa, C A Ponce, C E Cabrera, F Cumsille, F Gigliotti.   

Abstract

To determine whether Pneumocystis carinii is associated with clinical illness in the competent host, 107 normal, healthy infants were enrolled in a 2-year prospective cohort study in Chile. P. carinii was identified by specific stains and nested--deoxyribonucleic acid (DNA) amplification of the large subunit mitochondrial ribosomal ribonucleic acid gene of P. carinii f. sp. hominis, and seroconversion was assessed by enzyme-linked immunosorbent assay of serum samples drawn every 2 months. P. carinii DNA was identified in nasopharyngeal aspirates obtained during episodes of mild respiratory infection in 24 (32%) of 74 infants from whom specimens were available for testing. Three (12.5%) of those 24 infants versus 0 of 50 infants who tested negative for P. carinii had apnea episodes. Seroconversion developed in 67 (85%) of 79 infants who remained in the study by 20 months of age and occurred in the absence of any symptoms of disease in 14 (20.8%). The study indicates that P. carinii DNA can be frequently detected in healthy infants, and it raises the hypothesis that they may be an infectious reservoir of P. carinii in the community. Further investigation is needed to identify whether P. carinii causes overt respiratory disease in infants.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11247708     DOI: 10.1086/319340

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  100 in total

1.  Alveolar macrophages in neonatal mice are inherently unresponsive to Pneumocystis murina infection.

Authors:  Cathryn Kurkjian; Melissa Hollifield; J Louise Lines; Amy Rogosky; Kerry M Empey; Mahboob Qureshi; Stephen A Brown; Beth A Garvy
Journal:  Infect Immun       Date:  2012-06-04       Impact factor: 3.441

2.  Seroepidemiological study of Pneumocystis jirovecii infection in healthy infants in Chile using recombinant fragments of the P. jirovecii major surface glycoprotein.

Authors:  Kpandja Djawe; Kieran R Daly; Sergio L Vargas; M Elena Santolaya; Carolina A Ponce; Rebeca Bustamante; Judith Koch; Linda Levin; Peter D Walzer
Journal:  Int J Infect Dis       Date:  2010-12       Impact factor: 3.623

Review 3.  Pneumocystis.

Authors:  Francis Gigliotti; Andrew H Limper; Terry Wright
Journal:  Cold Spring Harb Perspect Med       Date:  2014-11-03       Impact factor: 6.915

4.  Contribution of T cell subsets to the pathophysiology of Pneumocystis-related immunorestitution disease.

Authors:  Samir P Bhagwat; Francis Gigliotti; Haodong Xu; Terry W Wright
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-08-04       Impact factor: 5.464

5.  Chitinases in Pneumocystis carinii pneumonia.

Authors:  Leah R Villegas; Theodore J Kottom; Andrew H Limper
Journal:  Med Microbiol Immunol       Date:  2012-04-26       Impact factor: 3.402

6.  Trimethoprim-sulfamethoxazole treatment does not reverse obstructive pulmonary changes in pneumocystis-colonized nonhuman primates with SHIV infection.

Authors:  Heather M Kling; Timothy W Shipley; Siobhan Guyach; Rebecca Tarantelli; Alison Morris; Karen A Norris
Journal:  J Acquir Immune Defic Syndr       Date:  2014-04-01       Impact factor: 3.731

Review 7.  Current understanding of Pneumocystis immunology.

Authors:  Michelle N Kelly; Judd E Shellito
Journal:  Future Microbiol       Date:  2010-01       Impact factor: 3.165

Review 8.  Prophylaxis for Pneumocystis pneumonia (PCP) in non-HIV immunocompromised patients.

Authors:  Anat Stern; Hefziba Green; Mical Paul; Liat Vidal; Leonard Leibovici
Journal:  Cochrane Database Syst Rev       Date:  2014-10-01

9.  Primary pneumocystis infection in infants hospitalized with acute respiratory tract infection.

Authors:  Hans Henrik Larsen; Marie-Louise von Linstow; Bettina Lundgren; Birthe Høgh; Henrik Westh; Jens D Lundgren
Journal:  Emerg Infect Dis       Date:  2007-01       Impact factor: 6.883

10.  Healthcare worker occupation and immune response to Pneumocystis jirovecii.

Authors:  Renuka Tipirneni; Kieran R Daly; Leah G Jarlsberg; Judy V Koch; Alexandra Swartzman; Brenna M Roth; Peter D Walzer; Laurence Huang
Journal:  Emerg Infect Dis       Date:  2009-10       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.